257 related articles for article (PubMed ID: 32463570)
1. MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88.
Xu T; Pan L; Li L; Hu S; Zhou H; Yang C; Yang J; Li H; Liu Y; Meng X; Li J
J Cell Mol Med; 2020 Jul; 24(13):7127-7140. PubMed ID: 32463570
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane protein 88 attenuates liver fibrosis by promoting apoptosis and reversion of activated hepatic stellate cells.
Cai SP; Cheng XY; Chen PJ; Pan XY; Xu T; Huang C; Meng XM; Li J
Mol Immunol; 2016 Dec; 80():58-67. PubMed ID: 27833039
[TBL] [Abstract][Full Text] [Related]
3. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells.
Li ZJ; Ou-Yang PH; Han XP
Cell Signal; 2014 Jan; 26(1):141-8. PubMed ID: 24100264
[TBL] [Abstract][Full Text] [Related]
4. Activation of Hepatic Stellate Cells is Inhibited by microRNA-378a-3p via Wnt10a.
Yu F; Fan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 39(6):2409-2420. PubMed ID: 27832641
[TBL] [Abstract][Full Text] [Related]
5. TMEM88 inhibits extracellular matrix expression in keloid fibroblasts.
Zhao H; Lu F; Cui S; Zhang X; Wang W; Si E; Yuan Z
Biomed Pharmacother; 2017 Nov; 95():1436-1440. PubMed ID: 28946191
[TBL] [Abstract][Full Text] [Related]
6. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
[TBL] [Abstract][Full Text] [Related]
7. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.
Sun X; He Y; Ma TT; Huang C; Zhang L; Li J
Mol Cell Biochem; 2014 Mar; 388(1-2):11-23. PubMed ID: 24242045
[TBL] [Abstract][Full Text] [Related]
8. Pinostilbene hydrate suppresses hepatic stellate cell activation via inhibition of miR-17-5p-mediated Wnt/β-catenin pathway.
Zhou G; Li C; Zhan Y; Zhang R; Lv B; Geng W; Zheng J
Phytomedicine; 2020 Dec; 79():153321. PubMed ID: 32919323
[TBL] [Abstract][Full Text] [Related]
9. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells.
Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H
J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448
[TBL] [Abstract][Full Text] [Related]
10. Potent effects of dioscin against liver fibrosis.
Zhang X; Han X; Yin L; Xu L; Qi Y; Xu Y; Sun H; Lin Y; Liu K; Peng J
Sci Rep; 2015 Apr; 5():9713. PubMed ID: 25853178
[TBL] [Abstract][Full Text] [Related]
11. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
12. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
Fu J; Wu B; Zhong S; Deng W; Lin F
Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
14. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl
Liu QQ; Chen J; Ma T; Huang W; Lu CH
Sci Rep; 2024 Apr; 14(1):9425. PubMed ID: 38658618
[TBL] [Abstract][Full Text] [Related]
15. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
18. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
[TBL] [Abstract][Full Text] [Related]
19. Effects of Siniruangan Recipe on Proliferation, Apoptosis and Activation of Human Hepatic Stellate Cell Line LX-2.
Liu J; Zhao G; Ai B; He Y; Mei M; Zou J; Xiao B; Yin Z
Pharmacology; 2019; 104(5-6):342-351. PubMed ID: 31390636
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane protein 88 inhibits transforming growth factor-β1-induced-extracellular matrix accumulation and epithelial-mesenchymal transition program in human pleural mesothelial cells through modulating TGF-β1/Smad pathway.
Sun Z; Ning Q; Li H; Hu T; Tang L; Wen Q; Shen L
J Recept Signal Transduct Res; 2022 Feb; 42(1):60-66. PubMed ID: 33167758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
